Full-Time

Director of Research Finance

Posted on 5/9/2026

Tufts Medicine

Tufts Medicine

501-1,000 employees

Integrated health system delivering connected care

Compensation Overview

$148k - $188.7k/yr

Boston, MA, USA

Hybrid

Category
Accounting (2)
,
Requirements
  • Bachelor's degree in accounting or related field
  • Ten (10) years of progressively responsible research finance experience, including five (5) years of management experience
  • Master's degree in related field (preferred)
  • Experience in an Academic Medical Center, medical school, or integrated health system (preferred)
  • Excellent communication (both written and verbal), interpersonal, problem solving, organizational, and customer service skills
  • Ability to present and summarize complex financial information for personnel who may not be familiar with research finance and accounting practices
  • Thorough knowledge of OMB Circulars A-21, A-110, and A-133, as well as 45 CFR 74 Appendix E (OASC-3, Cost Principles for Hospitals)
  • Ability to direct a team of individuals working in a remote capacity and affect a high level of performance
  • Ability to lead a team of skilled professionals to perform all financial functions for the research enterprise to a high level
Responsibilities
  • Directs the fiscal requirements for grants & contracts, sundry and permanently and temporarily restricted funds, and research business & operations management activities, including hospital research consolidated budgeting and reporting, financial reporting to all federal and private foundations, accounts receivable/cash management, management accounting, implementation of internal controls, reporting systems review and maintenance, management of donor imposed restrictions, and audit coordination.
  • Directs various personnel functions including, but not limited to, performance management, operational issues, problem resolution, compliance, time management, and customer service.
  • Provides monthly/year end consolidated financial reporting of grants, contracts and special funds for the hospital consolidated financial statements. Provide monthly executive-level financial analyses to allow for strategic planning and tracking of key financial performance indicators for the research product-line, including but not limited to, the research profit and loss statement, and both space density and indirect recovery analysis.
  • Directs the proposal preparation and negotiates the Tufts-MC facilities & administrative cost and fringe benefit rates with our cognizant federal agency, the DHHS Division of Cost Allocation.
  • Develops, organizes, completes, and provides on-going variance analysis for research and special funds annual budget in collaboration with executive management and the Vice President of Research Administration.
  • Responsible for the maintenance and data integrity of the research and special funds ledger, sub-ledger, and data bases, and other system functionality as well as all associated processes and internal controls.
  • Directs the completion of annually required financial reports to different funding sources, including federal and state agencies, to ensure continuation and renewals of grant and contract awards.
  • Serves as the chief regulatory fiscal specialist to all researchers, research administrators, and management related to federal grants and contracts.
  • Develops research accounting policies and procedures for internal control and compliance with federal requirements in all financial aspects of grants and contracts. Implements new research accounting policies and trains internal stakeholders as required.
  • Works with both internal and external auditors/stakeholders to coordinate the annual OMB Uniform Grant Guidance (UGG) audit, Uniform Financial Report (UFR), Federal Emergency Management Agency (FEMA) grant submission, as it pertains to obligations of the system-wide enterprise.
  • Works with the Leadership to provide guidance and recommendations for the establishment of internal policies regarding both economic and compliance issues. Implements new fiscal policies as required.
  • Compiles research facilities, administrative, and fringe benefit cost data, and allocation information, and directs the preparation of the hospital’s research rate proposals in accordance with applicable regulations.
  • Responds to financial compliance issues raised by Compliance and Internal Audit and implements corrective action plans as necessary.
  • Reviews and authorizes hospital research core facilities annual hospital-wide charge rates and budgets brought forward by Research Administration Directors.
  • Works collaboratively with Leadership to oversee the business and financial operations of the core facilities serving the needs of the research community.
  • Directs the preparation of all fiscal year-end and interim research audit schedules and analyses required by Tufts MC external auditors for inclusion in the hospital’s year-end audited financial statements.
  • Directs any on-site audits or reviews performed by granting agencies, independent auditors or consulting groups.
  • Monitors federal compliance with the hospital’s time and effort reporting system.
  • Working in collaboration with Leadership, requests formal corrective action plans from the Research Administration Directors, when necessary, in key fiscal compliance risk areas, to ensure maintenance of a proper internal control environment for the management of federal grants.
  • Identifies and develops design revisions and enhancements to the grants, contracts and special funds financial reporting and management information systems.
Desired Qualifications
  • Master’s degree in related field (preferred)
  • Experience in an Academic Medical Center, medical school, or integrated health system (preferred)

Tufts Medicine is an integrated health system in Massachusetts that combines academic medical centers, community hospitals, a large home care network, and a clinically integrated physician network to deliver coordinated care. It includes Tufts Medical Center, Lowell General, MelroseWakefield, home health services, and a broad physician network, enabling care across settings. The system coordinates hospitals, doctors, and home care under one strategy to manage the patient journey, reduce fragmentation, and control costs while maintaining quality. Its goal is to deliver high-quality care at the lowest possible cost, expand access, and transform how people engage with healthcare.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Burlington, Massachusetts

Founded

2014

Simplify Jobs

Simplify's Take

What believers are saying

  • Navvis partnership scales risk-based contracts across Medicare, Medicaid, commercial populations.
  • Herman's 30 years leadership boosts academic and community health operations.
  • NENA merger strengthens high-margin neuroscience services in Merrimack Valley.

What critics are saying

  • Herman's LGH experience fails in Boston's competitive market, causing underperformance.
  • Navvis dependency locks in vendor risks, eroding edge against Partners HealthCare.
  • 174 layoffs fragment operations, impairing Navvis execution and care coordination.

What makes Tufts Medicine unique

  • Tufts Medicine partners exclusively with Navvis to scale value-based care.
  • Acquires New England Neurological Associates for neuroscience expertise.
  • Appoints John Herman, ex-Penn Medicine CEO, as Tufts Medical Center President.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Tufts Medicine who can refer or advise you

Benefits

401(k) Company Match

403(b) Retirement Plan

Tuition Reimbursement

Company News

Aalborg University
Dec 10th, 2025
Persistent inequity in survival after atrial fibrillation

Persistent inequity in survival after atrial fibrillation. Atrial fibrillation, also known as AF or Afib, is one of the most common cardiovascular diseases. In fact, one in three individuals can expect to be diagnosed by the condition, which increases the risk of serious complications such as heart failure and stroke. Despite significant advances in the treatment of atrial fibrillation, a new Danish study from Aalborg University shows that social inequities in survival have remained virtually unchanged over the past 20 years. The article has just been published in the internationally recognized journal The Lancet Public Health in collaboration with the University of Liverpool, Tufts Medical Center in Boston, and Boston University. The study is based on nationwide Danish registry data from more than 380,000 patients diagnosed with atrial fibrillation between 2000 and 2022 and documents inequities in income, education, and social relationships still have a major impact on life expectancy after diagnosis. Individuals diagnosed with AF who have a low income live on average 2.5 years shorter than those with high income. Low educational level results in a loss of 1.8 years of life, while living alone costs about 1.6 years. "Advances in the management and treatment of atrial fibrillation have improved survival for everyone but have not closed the gap between social groups. This is clearly a problem in a tax-funded universal healthcare system with formally equal access to treatment for all - especially when we know how much prevention can actually matter," says the study's lead author, Nicklas Vinter, MD, PhD, and postdoctoral researcher at the Danish Center for Health Services Research at Aalborg University. He also points out that the global incidence of atrial fibrillation is rising, making the results relevant far beyond Denmark's borders. This is clearly a problem in a tax-funded universal healthcare system with formally equal access to treatment for all - especially when Adsl Aau know how much prevention can actually matter. Social and structural barriers must be addressed. According to Nicklas Vinter, the causes of inequity are not only linked to medical treatment but also to social and behavioral factors. For some patients, treatment guidelines can be difficult to understand and translate into concrete action, and many lack a social network that can provide practical support in everyday life. Therefore, the researchers behind the study propose a new tool, FAIR-PRO-AF, which can help decision-makers and researchers across sectors systematically reduce inequity and create continuous improvements. The tool is designed as a circular work cycle: first, the social factors associated with survival are mapped. Next, the barriers that hinder equity in access, quality, and effectiveness of treatment are identified. In the third step, concrete initiatives are prioritized and implemented, and finally, the effect is evaluated before the cycle moves on to the next round. "The social and structural barriers that limit patients' access to knowledge, resources, and support must be addressed if we want to improve prognoses for all. This requires a broader effort where the healthcare system collaborates with social and political actors," says Nicklas Vinter. Facts: Atrial fibrillation * Atrial fibrillation is the most common cardiac arrhythmia. * Symptoms of atrial fibrillation include shortness of breath, palpitations, and chest pain. * The condition is associated with increased mortality - on average, a patient with atrial fibrillation loses about two years of expected lifespan compared to individuals without the diagnosis. * In Denmark, more than 170,000 people live with the condition, * Each year, more than 20,000 Danes receive the new diagnosis. Read the scientific article: Temporal trends in associations between social drivers and life-years lost in newly diagnosed atrial fibrillation in Denmark, 2000 - 22: a nationwide cohort study Published in The Lancet Public Health, December 2025. Authors: Nicklas Vinter, Søren Paaske Johnsen, Gregory Yoke Hong Lip, Ludovic Trinquart, Lars Frost and Emelia J. Benjamin.

Central Penn Business Journal
Jun 30th, 2025
Former CEO of Penn Medicine LGH named president of Tufts Medical Center

Former Penn Medicine Lancaster General Health Chief Executive Officer John Herman has been appointed as the new President of Tufts Medical Center in Boston, the health system's academic medical center.

The Indian EYE
May 30th, 2025
Dr. Soma Sengupta appointed Tufts University's New Chair of the Department of Neurology

Dr. Soma Sengupta, MD, PhD, MBA, FRCP, FANA, FAAN will join Tufts Medical Center (Tufts MC) as Chair of the Department of Neurology and Neurologist-in-Chief in September 2025.

The Boston Globe
Mar 20th, 2025
Lawrence General, Holy Family hospitals appoint new interim CEO

After a challenging year for Lawrence General Hospital and Holy Family Hospital, former Tufts Medical executive Diana L. Richardson will take over as interim president and CEO next month, the hospital system announced Thursday.

Medical Device Network
Sep 26th, 2024
CereVasc's endovascular device may offer gene therapy delivery pathway to brain

US-based CereVasc collaborated with researchers from the UMass Chan Medical School and Tufts Medical Center for the study.